Dyne Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Dyne Therapeutics, Inc. (DYN) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.440.120.260.380.30
Short-Term Investments0.210.000.080.180.04
Cash & Short-Term Investments0.640.120.260.380.35
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.020.010.010.010.00
Total Current Assets0.660.130.270.380.35
Non-Current Assets
Property, Plant & Equipment (Net)0.030.030.040.040.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.030.030.040.040.00
Total Assets0.690.170.310.430.35
Current Liabilities
Accounts Payable0.010.050.020.020.00
Short-Term Debt0.010.000.000.000.00
Accrued Liabilities0.030.020.020.020.01
Other Current Liabilities0.030.010.010.010.00
Total Current Liabilities0.040.050.030.030.01
Non-Current Liabilities
Long-Term Debt0.020.020.030.030.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.020.020.030.030.00
Total Liabilities0.060.070.050.060.01
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-0.95-0.63-0.40-0.23-0.08
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.580.720.650.600.42
Shares Outstanding0.100.060.060.050.00
Total Stockholders' Equity0.630.090.250.370.34
Total Liabilities & Equity0.690.170.310.430.35